Buyback of Equity Shares of Ajanta Pharma Limited

 Buyback of Equity Shares of Ajanta Pharma Limited (the “Company”) by way of tender offer from existing shareholders pursuant to the provisions of the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018, as amended (“Buyback Regulations”) and the Companies Act, 2013, as amended (“Buyback”)

Dear Sir/Ma’am,

With reference to the captioned Buyback and in furtherance of our earlier intimation regarding submission of Public Announcement dated March 13, 2023 published on March 14, 2023, please find enclosed the Letter of Offer dated March 28, 2023 along with the Tender Forms for demat and physical shareholders, which are being dispatched by the Company to the Eligible Shareholders within two working days from the Record Date being March 24, 2023.

You are requested to take note of the following schedule of activities in relation to the Buyback:

 

S.No.	Activity	Day	Date
1.	Record Date for determining the names of the Eligible Shareholders and the Buyback Entitlement	Friday	March 24, 2023
2.	Filing of Letter of Offer	Tuesday	March 28, 2023
3.	Buyback Opening Date	Friday	March 31, 2023
4.	Buyback Closing Date	Monday	April 10, 2023
5.	Last date of receipt of completed Tender Forms and other specified documents including physical certificates (if and as applicable) by the Registrar to the Buyback	Monday	April 10, 2023
6.	Last date of completion of settlement of bids by the Clearing Corporation/ Stock Exchanges*	Tuesday	April 18, 2023

* This activity may happen on or before the last date mentioned herein above.

 

The Letter of Offer along with the Tender Forms for demat and physical shareholders are available on website                              of                              the                              Company                                          (i.e., https://ajantapharma.com/ajanta/Investors/investor_information_buyback/?year=2022-23)